Healthcare
Panacea Life Sciences Holdings, Inc.(PLSH)
Live Price
Offline$0.035
+0.00% today
Window Change
+0.00%
Window
May 29, 2026 โ Jun 18, 2026
- Market Cap
- โ
- Revenue Growth
- -77.8%
- EPS Growth
- +77.8%
- Dividend Yield
- 0.0%
Historical coverage is still filling in
This 1Y daily history view is currently sparse. Use it as directional context while we continue backfilling more history.
Coverage: 15 bars ยท May 29, 2026 โ Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Panacea Life Sciences Holdings, Inc. (PLSH) is a Healthcare stock with listed on OTC. The stock last traded around $0.04 and up 0.0% across the available one-year price window (May 29, 2026 โ Jun 18, 2026). Baseline metrics include revenue growth of -77.8%, EPS growth of +77.8%, a dividend yield of 0.0%. What stands out right now is revenue -77.8%, EPS +77.8%, free cash flow -10.4% with operating margin -192.6% and ROIC -31.3%. Valuation is more restrained than many high-expectation growth names at price/sales 0.7. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines PLSH price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
-77.8% vs +7.6% peer median
Operating Margin
Below sector median
-192.6% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 12, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at -77.8% and EPS is at +77.8%, with operating margin around -192.6%.
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
PLSH
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
PLSH Max Drawdown
-8.57%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for PLSH and SPY.
Company Overview
Panacea Life Sciences Holdings, Inc.
Other OTC
Panacea Life Sciences Holdings, Inc., a seed to sale cannabinoid and nutraceutical manufacturer and research company, develops and produces natural pharmaceutical alternatives for consumers and pets. The company manufactures and sells softgels, gummies, tinctures, sublingual tablets, cosmetics, and other topicals. It is also involved in the personal protection equipment (PPE) business, including importing and selling PPE hand sanitizers and masks, as well as white label and contract manufacturing sales to other cannabinoid companies, raw material sales, and tolling arrangements. The company was incorporated in 2008 and is headquartered in Greenwood Village, Colorado.
- Leadership
- Leslie A. Buttorff
- IPO Date
- Apr 4, 2022
- Employees
- 40
- Street Address
- 5910 South University Boulevard
- Mailing
- Greenwood Village, CO, 80121
- Region
- Greenwood Village, CO, US
- Reporting Currency
- USD
- Investor Line
- 800 985 0515
- Last Updated
- May 3, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- 42.2
- Price/Sales
- 0.7
- Price/Book
- 0.3
Growth
- Revenue
- -77.8%
- EPS
- +77.8%
- Free Cash Flow
- -10.4%
Profitability
- Gross Margin
- -133.9%
- Operating Margin
- -192.6%
- Net Margin
- -45.8%
- ROE
- 14.7%
- ROIC
- -31.3%
Balance Sheet
- Debt/Equity
- 0.04
- Current Ratio
- 15.48
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.